関節リウマチ(RA)治療薬の世界市場...市場調査レポートについてご紹介

【英文タイトル】Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 9
2.1 Disease Introduction 9
2.2 Symptoms 10
2.3 Etiology 10
2.4 Pathophysiology 10
2.5 Diagnosis 11
2.5.1 Physical Examination 11
2.5.2 Blood Tests 11
2.5.3 1987 Rheumatoid Arthritis Classification 12
2.5.4 The 2010 ACR-EULAR Classification Criteria for Rheumatoid Arthritis 12
2.6 Epidemiology 13
2.7 Co-morbidities and Complications 13
2.8 Disease Progression 14
2.9 Pharmacotherapy Algorithm 14
2.10 Treatment Options 16
2.10.1 Pharmacological 16
2.10.2 Methotrexate 16
2.10.3 Plaquenil (hydroxychloroquine) 16
2.10.4 Arava (leflunomide) 16
2.10.5 Azulfidine, Salazopyrin (sulfasalazine) 17
2.10.6 Neoral (cyclosporine) 17
2.10.7 Prograf (tacrolimus) 17
2.10.8 Xeljanz (tofacitinib) 17
2.11 Other Non-biologics 17
2.11.1 Non-steroidal Anti-inflammatory Drugs 17
2.11.2 Painkillers 18
2.11.3 Glucocorticoids 18
2.12 Biologic Disease-Modifying Anti-rheumatic Drugs 18
2.12.1 Tumor Necrosis Factor Alpha Inhibitors 18
2.12.2 Interleukin Inhibitors 18
2.12.3 Other Biologics that Target B- and T-Cell Antigens 19
2.13 Disease Scoring Methods for Measuring Treatment Efficacy 19
2.13.1 Radiographic Progression 19
2.13.2 Clinical Disease Activity Index and Simplified Disease Activity Index 19
2.13.3 Disease Activity Score-28 19
2.13.4 American College of Rheumatology 20
2.13.5 Health Assessment Questionnaire 20
3 Marketed Products 21
3.1 Overview 21
3.2 Small-Molecule Disease-Modifying Anti-rheumatic Drugs 21
3.2.1 Methotrexate-Based Products 21
3.2.2 Xeljanz (tofacitinib) – Pfizer 22
3.3 Biologic Disease-Modifying Anti-rheumatic Drugs 23
3.3.1 Remicade (infliximab) – Johnson and Johnson, Merck 23
3.3.2 Remsima – infliximab biosimilar 24
3.3.3 Humira (adalimumab) – Abbvie 24
3.3.4 Enbrel (etanercept) – Amgen, Pfizer and Takeda Pharmaceutical 26
3.3.5 Rituxan (rituximab) – Genentech (Roche), Biogen IDEC 27
3.3.6 Reditux (Non-comparable Biologic of Rituxan) 28
3.3.7 AcellBia (rituximab biosimilar) 28
3.3.8 Orencia (abatacept) – Bristol-Myers Squibb 29
3.3.9 Simponi (golimumab) – Johnson and Johnson, Merck 30
3.3.10 Cimzia (certolizumab pegol) – UCB 31
3.3.11 Kineret (anakinra) – Swedish Orphan Biovitrum 32
3.3.12 Actemra (tocilizumab) – Roche 33
3.3.13 Comparative Safety and Efficacy 34
3.4 Unmet Need 37
4 Pipeline Landscape 38
4.1 Overview 38
4.2 Pipeline Distribution by Phase of Development, Molecule Type, Route of Administration and Novelty 38
4.3 Pipeline Distribution by Mechanism of Action 40
4.3.1 Cytokine Inhibitors 41
4.3.2 B- and T-cells 43
4.3.3 Intracellular kinases 44
5 Clinical Trial Analysis 45
5.1 Overall Attrition Rate 45
5.2 Attrition Rate by Phase, Molecule Type and Method of Administration 45
5.3 Average Clinical Trial Size by Molecule Type 48
5.4 Average Clinical Trial Size by Mechanism of Action 51
5.5 Average Clinical Trial Duration per Molecule Type by Product 53
5.6 Average Clinical Trial Duration per Mechanism of Action by Product 55
5.7 Primary and Secondary End Points 56
5.8 Summary 57
5.9 Promising Pipeline Drugs 57
5.9.1 Phase III Programs 57
5.9.2 Phase II Programs 64
5.10 Comparative Heat Map 66
6 Market Forecasts to 2020 69
6.1 Geographical Markets 69
6.2 Global Market 69
6.2.1 Treatment Usage Patterns 70
6.2.2 Market Size 71
6.3 North America 72
6.3.1 Treatment Usage Patterns 72
6.3.2 Annual Cost of Therapy 72
6.3.3 Market Size 74
6.4 Top-Five EU Markets 75
6.4.1 Treatment Usage Patterns 75
6.4.2 Annual Cost of Therapy 76
6.4.3 Market Size 77
6.5 Japan 78
6.5.1 Treatment Usage Patterns 78
6.5.2 Annual Cost of Therapy 78
6.5.3 Market Size 79
6.6 Drivers and Barriers of Rheumatoid Arthritis Therapeutic Market 79
6.6.1 Drivers 79
6.6.2 Barriers 80
7 Deals and Strategic Consolidations 81
7.1 Licensing agreements 81
7.1.1 Deal Values by Therapeutic Molecule Types 83
7.1.2 Deal Values by Therapeutic mechanism of administration 85
7.1.3 AstraZeneca Enters into Licensing Agreement with Rigel Pharma for fostamatinib disodium 87
7.1.4 Alder Biopharmaceuticals Enters into Licensing Deal with Bristol-Myers Squibb Company Alder Biopharmaceuticals for Clazakizumab 87
7.1.5 Janssen Biotech enters into a licensing deal with Astellas Pharma for Peficitinib 87
7.1.6 Ablynx enters into a licensing deal with Abbvie for the Nanobody ALX-006 87
7.2 Co-development 88
7.2.1 Deal Values by Therapeutic Molecule Types and Phase 89
7.2.2 Deal Values by Therapeutic mechanism of administration and Phase 91
7.2.3 GlaxoSmithKline enters into Global Agreement with Archemix 93
7.2.4 Abbott Laboratories Enters into Global Collaboration with Galapagos for filgotinib 93
7.2.5 Chroma Therapeutics Enters into a Co-development Agreement with GlaxoSmithKline 93
8 Appendix 94
8.1 All Pipeline Drugs by Phase of Development 94
8.1.1 Discovery 94
8.1.2 Preclinical 98
8.1.3 IND-CTA Filed 108
8.1.4 Phase I 109
8.1.5 Phase II 111
8.1.6 Phase III 113
8.2 Market Forecasts to 2020 115
8.3 Abbreviations 119
8.4 References 120
8.4.1 References for Error! Reference source not found. 132
8.4.2 References for Figure 32 134
8.5 Research Methodology 135
8.5.1 Secondary Research 136
8.5.2 Marketed Product Profiles 136
8.5.3 Late-Stage Pipeline Candidates 136
8.5.4 Comparative Efficacy and Safety Heat Map for Marketed and Pipeline Products 137
8.5.5 Pipeline Analysis 137
8.5.6 Forecasting Model 138
8.5.7 Deals Data Analysis 139
8.6 Contact Us 139
8.7 Disclaimer 139


【レポート販売概要】

■ タイトル:関節リウマチ(RA)治療薬の世界市場
■ 英文:Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth
■ 発行日:2014年12月31日
■ 調査会社:GBI Research
■ 商品コード:GBIHC354MR
■ 調査対象地域:グローバル
  • 掘削孔拡大システムの世界市場2019-2023
    About Borehole Enlargement Systems Borehole enlargement is the process of drilling using a tool to enlarge a wellbore. The global borehole enlargement systems market is segmented based on geography and application. Technavio’s analysts forecast the global borehole enlargement systems market to grow at a CAGR of 4.46% during the period 2019-2023. Covered in this report The report covers the present …
  • 医療産業向けモバイルソリューションの世界市場:モバイル端末、モバイルアプリ、エンタープライズ・プラットフォーム
    The global healthcare mobility solutions market is expected to grow at a lucrative CAGR of 25% to 30% during the forecast period (2015 to 2020). Factors such as rising adoption of mobile computers such as smartphones and tablets in healthcare systems, rising focus on patient-centric applications, better cost efficiency of mobility solutions resulting in streamlined workflow, shortage of nursing st …
  • 幹細胞治療の世界市場:自己幹細胞治療、アロジェネイック幹細胞治療
    According to Stratistics MRC, the stem cell therapy market is expected to grow at a CAGR of 37.6% during the forecast period 2015 to 2022. Rising awareness about stem cell therapies is the key factor driving the market growth. Furthermore, rising prevalence of chronic diseases, increasing approvals of clinical trials for stem cells therapy, increasing funds from government and private organization …
  • 世界のミネラルウール市場2015
    The Global Mineral Wool Industry Report 2015 is a professional and in-depth study on the current state of the Mineral Wool industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Mineral Wool market analysis is provided for the international markets including development trends, competitive landscape analy …
  • 歯科用消耗品の世界市場2017-2021:インプラント、クラウン、ブリッジ、歯科矯正、 歯周治療、生体材料
    ABSTRACTAbout Dental Consumables Dental consumables are a set of different dental products that are used in individuals to treat dental impairments, for tooth restoration, and in the treatment of associated gingival tissues. Dental consumables are a set of different dental products that are used in dental procedures. Dental implants are the commonly used dental consumables in the tooth restoration …
  • ブラジルの化粧品市場2015-2019
    Technavios research analyst predicts the cosmetics market in Brazil to grow at a CAGR of 11% during the forecast period. The increase in the number of working women is the primary driver for the growth of this market. The need to look fresh and presentable at the workplace is the key reason for the increase in expenditure on cosmetics by working women. Moreover, women in Brazil are now more inform …
  • 中国のヒートポンプ市場:Heat Pump Market in China 2014-2018
    TechNavio's analysts forecast the Heat Pump market in China to grow at a CAGR of 27.86 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for a reduction of greenhouse gases. The Heat Pump market in China has also been witnessing the increasing awareness of the latest technology. However, the need for high initial investment could pose a challe …
  • Rosetta Resources Inc.社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Rosetta Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Rosetta Resources Inc. (Rosetta Resources) is an independent oil and gas company. It acquires, explores and develops onshore energy resources in the US. The company engages in the production of oil, natural gas and natural gas liquids (NGLs). The core operating areas of the company are the E …
  • 世界のアジピン酸市場動向(~2019)
    The report covers the adipic acid market on the basis of material type, applications, and geography. The market data for these types is given with respect to volume (thousand tons) and value ($Million). The market value of adipic acid was estimated to be $5,884.6 million in 2012, and is projected to grow with a CAGR of 3.7% from 2014 to 2019. The data mentioned in the report are based on the globa …
  • 世界の水産飼料市場
    Fish require energy and essential nutrients for body-maintenance, movement, normal metabolic functions, and growth. Fish can obtain their energy and nutrients from natural food in ponds, from feed supplied by the farmers or from a combination of both the sources. Feed is a major expenditure for fish farmers as it accounts for 40% - 50% of the production cost. The global aquafeeds market is estimat …
  • プログラマブルロジックデバイス(PLD)の世界市場2019-2023
    About this market The global PLD market is growing due to the increasing deployment of base stations for telecommunication networks. The demand for base stations is increasing with the need for high-speed network connectivity technologies such as 4G-LTE and 5G. The increasing number of base stations will lead to the rise in the deployment of mobile communication equipment. Telecommunication equipm …
  • 帯状ヘルペス(シングルス)(Herpes Zoster (Shingles)):治療薬開発パイプライン動向(2015年上半期版)
    Herpes Zoster (Shingles) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H1 2015’, provides an overview of the Herpes Zoster (Shingles)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Herpes Zoster (Shingles), complete with comparative analysis at various stages, therapeutics assessme …
  • 中国のオンライン宝くじ市場2016-2020
    About Online Lottery in China Although online lottery is banned and stringent regulations have been imposed during the pilot run, it is one of the major sources of revenue for the government. Especially the lottery segment accounts for one the major revenue contributing segments in the overall gambling market in the country. Some of the major benefits of easing regulations on sports lottery includ …
  • 非アルコール性脂肪性肝炎(Non-Alcoholic Steatohepatitis)の治療薬パイプライン動向(2015年上半期版)
    Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, t …
  • 2014年イギリスの分子血液型・分類検査および感染症NAT(核酸増幅検査)市場
    Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and mar …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。